Publications | Flatiron Health | Non-small cell lung cancer

Browse every publication tagged Non-small cell lung cancer

October 2026
Comparison of patient characteristics and first-line treatment patterns in metastatic NSCLC: US and Finland cohorts to inform overall survival transportability analyses
October 2026
Controlling for what comes next: Estimating generalized direct effects of 1L therapy on real-world overall survival using counterfactual 2L distributions in advanced NSCLC
October 2026
Benchmarking as a tool for assessing cross-country comparability of survival evidence for HTA
October 2026
Association of serum sodium and outcomes in patients receiving checkpoint inhibition for metastatic NSCLC
October 2026
Leveraging large language models to characterize serious illness conversations in advanced non-small cell lung cancer
October 2026
Quality of care in US community oncology practices among patients with metastatic breast cancer and metastatic non-small cell lung cancer
August 2026
Real-world treatment duration and outcomes among patients with early-stage NSCLC receiving adjuvant osimertinib: a retrospective cohort study
August 2026
Genomic alterations without approved 1L targeted therapies in patients with NSCLC PD-L1 ≥50% treated with immunotherapy
August 2026
Real-world outcomes with chemoradiation and durvalumab consolidation in stage III KRAS G12C-mutant NSCLC in the US